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Abstract 
Rotary ventricular assist device (VAD) support of the cardiovascular system is susceptible to 
suction events due to the limited preload sensitivity of these devices. This may be of 
particular concern with  rotary biventricular support (BiVAD) where the native, flow-
balancing Starling response is diminished in both ventricles. The reliability of sensor and 
sensor-less based control systems which aim to control VAD flow based on preload have 
limitations  and thus an alternative solution is desired. This study introduces a compliant 
inflow cannula (CIC) which could improve the preload sensitivity of a rotary VAD by 
passively altering VAD flow depending on preload. To evaluate the design, both the CIC and 
a standard rigid inflow cannula were inserted into a mock circulation loop to enable 
biventricular heart failure support using configurations of atrial and ventricular inflow, and 
arterial outflow cannulation.  A range of left (LVAD) and right VAD (RVAD) rotational 
speeds were tested as well as  step changes in systemic/pulmonary vascular resistance to alter 
relative preloads, with resulting flow rates recorded. Simulated suction events were observed, 
particularly at higher VAD speeds, during support  with the rigid inflow cannula, while the   
CIC prevented suction events under all circumstances. The compliant section passively 
restricted its internal diameter as preload was reduced, which increased the VAD circuit 
resistance and thus reduced VAD flow. Therefore, a compliant inflow cannula could 
potentially be used as a passive control system to prevent suction events in rotary left, right 
and biventricular support. 
 
Keywords 
Compliant cannula, suction event, physiological control, biventricular assist device, heart 
failure. 
 
  
Introduction 
With a worldwide shortage of donor hearts, ventricular assist devices (VADs) are used as an 
alternative to heart transplantation to support end stage heart failure patients to recovery, 
future transplant or as a destination therapy [1]. VADs may be used to support the left 
(LVAD), right (RVAD) or both (BiVAD) sides of the heart. Ventricular dysfunction often 
occurs in the left ventricle, thus the  many patients requiring mechanical circulatory support 
receive only an LVAD. However, the incidence of right heart dysfunction after LVAD 
insertion may be as high as 48% [2, 3] and is considered one of the most serious 
complications within the LVAD postoperative period [4]. Should pharmaceutical treatment 
strategies such as pulmonary vasodilators or inotropic agents fail, then there is little option 
but to use mechanical circulatory support to assist the right heart. The requirement for RVAD 
placement varies greatly between institutes, and has been reported between 5 and 48% of 
LVAD supported patients [2, 5, 6]. Several issues are apparent with BiVAD support, such as 
pump design, pump placement and flow balancing [7]. 
 
In healthy humans, flow balancing between the systemic and pulmonary circulations is 
regulated by several closed loop biological control systems such as the Frank-Starling and 
baroreceptor responses [8, 9]. Pulsatile VADs, when operated in a full-to-empty mode, have 
an inherent flow balancing capability which ensures the native circulations are not over- or 
under-loaded [10]. However, rotary VADs are relatively preload insensitive [11] and are 
prone to flow imbalances. Support by just one device (eg. LVAD support) may rely on 
having the native control mechanism of one functional ventricle (eg. Right ventricle) to 
balance flow. However, sudden changes in circulatory demands for which the rotary LVAD 
cannot account for may upset this balance, and thus LVAD support alone is still susceptible 
to flow imbalances. This situation is further exacerbated with the use of two rotary VADs for 
biventricular support, as any remnant native control mechanisms are absent due to the 
diminished  left and right ventricular function. The few documented clinical studies of rotary 
biventricular support warn of haemodynamic instability [12-14] and report the importance of 
continued controller development to prevent pulmonary edema and suction events in the 
cannulated chambers. Suction events may result in harmful consequences such as full or 
partial / transient flow stoppages, endocardial damage and ventricular arrhythmias [15-18].  
 
In order to balance flows with two Gyro pumps, Nosé et al. [19] incorporated inlet pressure 
sensors in each VAD to regulate flow, like the Frank-Starling mechanism. However, blood 
pump control systems like these may be limited by the low reliability of long term blood 
pressure and flow sensors [20]. Endo et al. [12] used VAD current to determine points of 
suction and full support in order to operate the VAD between these two points. While sensor-
less systems such as this demonstrate promise, changes in the VAD circuit, such as the 
formation of thrombus, may give false estimations and lead to an inaccurate controller [21]. 
Reliability issues of sensor and sensor-less based control systems must be addressed before a 
reasonable solution can be found for clinical implementation.  
 
Passive control systems which don't rely on sensors or inferred data to control the pump, have 
previously been used in the field of biventricular mechanical circulatory support. Gaddum et 
al. [22] used a two-sided, floating hub which was passively displaced by changes in LVAD 
and RVAD afterload which altered the clearance between the hub and the BiVAD impellers. 
The passively altered clearance aimed to alter LVAD/RVAD efficiency and thus balance the 
flow rates. However, this system resulted in hypersensitivity to afterload and insensitivity to 
preload, thus rendering it incapable of providing complete BiVAD control. Passive self-
regulation is also used for the Cleveland Clinic continuous flow total artificial heart (TAH), 
which employs left and right supporting impellers on a single hub [23]. The position of the 
hub is dependent on the left / right atrial pressure difference and passively alters the right 
pump output through a change in outlet resistance, thus improving its preload sensitivity [24]. 
However, remnant ventricular contractility experienced in a BiVAD application may upset 
this ability for passive flow balance.  
 
Our group has previously presented the use of a collapsible inflow cannula reservoir as a 
passive control system to prevent suction events during extracorporeal circulatory support of 
the left heart [25]. However, the additional volume of the reservoir removes the possibility 
for implantation whilst  potentially promoting thrombus formation due to  possible regions of 
stagnant flow. Therefore, the aim of this study was to investigate the use of a compliant, in-
line inflow cannula (CIC) to improve the preload sensitivity of rotary VADs used in 
biventricular support, by passively controlling LVAD and RVAD outflow.  
 
  
Methods 
Mock Circulation Loop 
A physical five element Windkessel mock circulation loop (MCL) including systemic and 
pulmonary circulations was used for this study [26, 27]. Atrial and ventricular chambers were 
represented by 40 mm and 50 mm respectively clear, vertical polyvinyl chloride (PVC) pipes 
with tee section connecting the inflow, outflow and heart chamber. Atrial volume was, 
therefore, directly related to the hydrostatic pressure in the chamber. In brief, ventricular 
systole was controlled through a series of electropneumatic regulators (ITV2030-012BS5, 
SMC Pneumatics, Brisbane, AUS) and 3/2 way solenoid valves (VT325-035DLS, SMC 
Pneumatics, Brisbane, AUS) to provide passively filled heart chambers and variable 
contractility, heart rate and systolic time. A Starling response was implemented in both left 
and right ventricles which actively controlled ventricular contractility (through 
electropneumatic regulator supply current) based on ventricular preload [28]. Mechanical 
check valves were used to simulate the mitral, aortic, tricuspid and pulmonary valves to 
ensure unidirectional flow throughout the circuit. Four independent Windkessel chambers 
were employed to simulate lumped systemic and pulmonary arterial and venous compliance.  
Proportional control valves (EPV-375B, HASS Manufacturing, NY, U.S.A.) allowed easy 
manipulation of systemic (SVR) and pulmonary (PVR) vascular resistance.  Mechanical 
circulatory assistance was incorporated with cannulation through the atrium (AC) or ventricle 
(VC) for VAD inflow and the artery for VAD outflow. The working fluid throughout this 
study was a water/glycerol mixture (60/40% by mass) with similar viscosity and density to 
that of blood. 
 
Cannula Construction and Evaluation 
A smooth, 12 mm diameter rod was coated with two layers of 20 mL de-aired silicone 
(Silastomer P15, Dalchem, Cheltenham, Australia), with each layer allowed to set prior to 
adding the subsequent layer. The rod was removed, leaving a thin-walled CIC. The CIC had 
an average wall thickness of 2 mm, an inner diameter of 12 mm, a length of 100 mm, a 
priming volume of 22 mL and a compliance of approximately 0.125 mL/mmHg.  
 
MCL parameters were manipulated to represent a medically treated, severe biventricular 
heart failure situation without VAD support. A VentrAssist (Ventracor Ltd., Sydney, 
Australia) rotary LVAD was connected to the MCL initially via the left atrium for LVAD 
inflow and the aorta for LVAD outflow while a BP80 (Bio-Medicus, Inc., Eden Prairie, MN, 
USA) rotary RVAD was connected to the right atrium for RVAD inflow and the pulmonary 
artery for RVAD outflow (Figure 1). CICs were added to both the LVAD and RVAD inflow 
cannulae. VAD speeds were independently increased in increments of 100 RPM from 1800-
3000 RPM for LVAD and 400-2000 RPM for RVAD to simulate a gradual change in 
preload. Step changes in PVR (100 to 400 Dynes.s.cm-5) and SVR (1500 to 2500 Dynes.s.cm-
5) were independently made to induce sudden reductions in LVAD and RVAD preload 
respectively. All experiments were then repeated with the inflow cannulation site changed to 
the left and right ventricles. Finally, the study was repeated with the compliant inflow section 
replaced with rigid inflow cannula (RIC) made of PVC tubing for comparison. Suction events 
were defined as a left atrial pressure (LAP) or left ventricular volume equal to or less than 
zero. As this investigation focused on the haemodynamics leading to a suction event and 
preventing suction events occurring, no physical suction was represented in the system. 
 
Data Acquisition 
Haemodynamic and VAD parameters were captured at 100 Hz using a dSPACE acquisition 
system (DS1104, dSPACE, MI, USA). Systemic and pulmonary flow rates were recorded 
using magnetic flow meters (IFC010, KROHNE, Sweden) while LVAD and RVAD outlet 
flow rates were recorded with clamp on ultrasonic flow meters (TS410-10PXL, Transonic 
Systems, NY, USA). Circulatory and VAD pressures were recorded using silicon-based 
transducers (PX181B-015C5V, Omega Engineering, Connecticut, USA) while left and right 
ventricular volumes were recorded using a magnetostrictive level sensor (IK1A, GEFRAN, 
Italy). 
 
 
  
Results 
Results were compared in AC and VC for LVAD and RVAD support to determine the effect 
of replacing the RIC with a CIC. An example comparison between RIC and CIC is shown in 
Figure 2. As the LVAD speed was incrementally increased from 1800 to 2400 RPM, the end 
systolic left ventricular volume (LVVsys) gradually decreased, LVAD inflow cannula 
resistance (LVADRin) stayed relatively constant, and the mean systemic flow rate (MSQ) 
gradually increased for both RIC and CIC. As the LVADRin remained constant with VAD 
speeds between 2400 and 2900 RPM for the RIC, the LVVsys gradually reduced to 0 mL, 
thus resulting in a suction event (predicted when LVVsys <0mmHg). However, with the CIC, 
the LVADRin steadily increased with VAD speeds higher than 2400 RPM, thus passively 
reducing the MSQ and maintaining positive LVVsys and preventing a suction event. 
 
As LVAD speed was increased from 1800 to 3000 RPM, LVADRin remained relatively 
constant with the RIC (400 Dynes.s.cm-5), however increased from 400 to 3800 Dynes.s.cm-5 
and 400 to 1600 Dynes.s.cm-5 (shown in Figure 2) with the CIC in AC and VC respectively. 
This gradual LVADRin increase compensated for the LVAD speed increase, maintaining 
MSQ at approximately 4.8 L/min with both AC and VC whilst preserving positive LAP 
above 3mmHg and/or LVVsys above 70 mL (Figure 3). The onset profile of CIC restriction 
altered slightly when cannulation site was changed, with a rapid inflow restriction observed 
with AC at 2600 RPM compared to a gradual inflow restriction with VC. This can be 
attributed to the increased cannula inflow pressure caused by ventricular contractions that 
helped to cyclically stent the cannula open and prevent rapid collapse in VC. On the other 
hand, the constant LVADRin of the RIC allowed for flow rates to increase to 5.5L/min with 
increasing LVAD speed for both AC and VC before suction events (LAP / LVVsys ≤ 0 
mmHg / mL) were observed at 2800 RPM and 2900 RPM respectively.  
 
 
Similar trends were noted with RVAD support with the RIC and CIC. The RVAD inflow 
cannula resistance (RVADRin) remained relatively constant (1100 Dynes.s.cm-5) with the 
RIC when RVAD speed was incrementally increased from 400 to 1500 RPM, allowing mean 
pulmonary flow rates of approximately 5.3 L/min before suction events occurred in both AC 
and VC. As the RVAD speed was increased from 400 to 2000 RPM with the CIC, RVADRin 
gradually increased from 1100 to 7000 Dynes.s.cm-5 and 1100 to 6000 Dynes.s.cm-5 for AC 
and VC respectively. The increased RVADRin served to maintain mean pulmonary flow rate 
at approximately 5.1 and 4.6 L/min for AC and VC respectively and prevent suction events 
by maintaining right atrial pressure above 3 mmHg and/or end systolic right ventricular 
volume above 50 mL (Figure 4). It should be noted that while these flow rates appear low for 
the reported suction events, changes in SVR or PVR were not incorporated in this test. 
Therefore, systemic and pulmonary arterial pressures were at high levels (MAP ≈ 110 mmHg 
and MPAP ≈ 25 mmHg) when flow rates were approximately 5 L/min. 
 
Results were also taken to demonstrate the response of the RIC and CIC to a step change in 
SVR or PVR (Table 1). In left AC, a change in PVR from 100 to 400 Dynes.s.cm-5 resulted in 
a LAP reduction from 7.9 to 0 mmHg with the RIC, indicating a suction event, while the CIC 
maintained LAP at 5mmHg. The haemodynamics in Table 1 suggest that a mean aortic 
pressure (MAP) and MSQ of 95 mmHg and 4.65 L/min respectively were maintained when 
LAP reached 0 mmHg with the RIC. However, these results are an indication of the 
haemodynamics directly prior to the suction event occurring as no mechanical occlusion was 
included in our experimental apparatus. With the CIC, however, the MAP and MSQ dropped 
to 67 mmHg and 3.95 L/min respectively as the LVADRin increased from 550 to 1800 
Dynes.s.cm-5. Reductions in MSQ (AC:  4.65 L/min, VC: 4.4 L/min) were also noted with the 
RIC due to the increased PVR, however MAP was not reduced significantly. With CIC and 
LVAD VC however, the reduction in MAP (99 to 74 mmHg) and MSQ (5 to 4.1 L/min) was 
not as significant due to the remaining ventricular contractility opening the CIC with each 
pulse and reducing the change in LVADRin (590 to 1100 Dynes.s.cm-5) compared to that 
seen in AC (550 – 1800 Dynes.s.cm-5). Positive LVVsys was maintained with the CIC (31 
mL), while a suction event occurred shortly after the PVR increase with the RIC.  
 
Similar trends were noted for RVAD support, as suction events occurred with the RIC after 
the sudden increase in SVR, while the CIC maintained positive right ventricular systolic 
volume (27 mL) with VC and right atrial pressure (3.1 mmHg) with AC. In both cases with 
the CIC, mean pulmonary flow rate was reduced (AC: 3.65 L/min, VC: 3.75 L/min), however 
a similar (but slightly smaller) reduction was also noted with the RIC (AC: 3.84 L/min, VC: 
3.92 L/min) due to the large increase in SVR. 
 
 
Discussion 
The use of rotary blood pumps to support patients with end stage heart failure continues to 
increase [24]. These devices, used for left, right or biventricular support, do not possess 
sufficient preload sensitivity to mimic the native Starling mechanism seen in healthy hearts 
and are susceptible to flow balancing issues and thus harmful suction events [11, 29]. This is 
particularly noticeable in biventricular support where both failing ventricles are lacking a 
normal Starling mechanism [29]. Previous attempts at BiVAD control have reported sensor 
drift [14], demonstrating the need for either a reliable sensor, reliable sensor-less controller, 
or a passive control mechanism. This paper details the use of a CIC which was capable of 
providing passive control of LVAD and / or RVAD flow based on preload in AC and VC.   
 
Previous reports have demonstrated the ease with which suction events can occur with rotary 
VAD support [17, 30]. Our study revealed similar results with a RIC in AC and VC by 
simulating incremental changes in LVAD speed, RVAD speed, SVR or PVR. However, the 
addition of the CIC prevented suction events in all cases, even at VAD speeds far greater than 
those reached until suction with the RIC. The mechanism of suction prevention with the CIC 
is fairly simple, and relies on the passively increasing resistance of the VAD circuit (via a 
reduction in cannula volume and thus diameter) as preload is reduced. This resistance 
increase alters the flow, rather than completely restricting it, and therefore preserves positive 
atrial and ventricular pressures and volumes while maintaining sufficient cardiac output. The 
reduction in cardiac output was never more than 27% with the LVAD or RVAD CIC 
evaluated under increases in SVR and PVR in AC and VC. While the reduction in cardiac 
output could be considered significant, it prevented total occlusion of the inflow cannula by 
the ventricle walls and thus complete or intermittent cessation of flow which would be 
expected during a suction event. Meanwhile, the maximum reduction in cardiac output with 
the RIC was 23% prior to the suction event, and can be attributed to the reduction in 
ventricular contractility due to the MCL Starling response and the limited preload sensitivity 
of the of the rotary VAD.  
 
The preload sensitivity of the VAD supported left ventricle, calculated by dividing the change 
in flow rate by the change in left atrial pressure from the step change in PVR test, averaged 
0.0627 L/min/mmHg for AC and VC with the RIC. This compares closely with results 
reported by Salamonsen et al. [11], who reported rotary LVAD preload sensitivity to vary 
between 0.03 and 0.31 L/min/mmHg. Addition of the CIC increased average preload 
sensitivity to 0.343 L/min/mmHg for AC and VC, which slightly exceeded values previously 
reported for the healthy human left ventricle (0.213 L/min/mmHg) [11]. However, increases 
in cardiac demand beyond that produced when the CIC is in its most expanded state may still 
require additional control strategies. 
 
Passive restriction of the CIC is not only related to VAD preload. The cannulation site 
influenced the restriction of the compliant section as the remnant ventricular contractility 
served to keep the restricted section open, thus decreasing the VAD inflow cannula 
resistance. This was less noticeable, however, at lower ventricular volumes as the Starling 
mechanism implemented in the MCL ventricles decreased contractility as ventricular preload 
reduced. Distance and orientation of the compliant section from the cannulated chamber also 
altered the nature of restriction as the increased pressure head with lower placement (with 
respect to the cannulated chamber) of the compliant section delayed the passive restriction. In 
the clinical setting,  the compliant section should be placed as close as possible to the 
cannulated chamber, thus rendering placement effects and changes in body position 
negligible. Meanwhile, the compliance and unstressed cannula dimensions influenced the 
performance of the compliant inflow cannula and may be used to improve the passive 
restriction mechanism.  
 
While this study presented an in-vitro evaluation of the CIC concept, there are several 
features that must be addressed before clinical implementation. The compliance of the 
restricting segment must be optimized, while appropriate biomaterials must be investigated to 
ensure the degree of compliance can be met. Implantability issues, such as the potential for 
tissue growth around the compliant section and its implications on device compliance must 
be addressed. Potential for increased haemolysis due to the introduction of a stenosis and 
‘fluttering’, as well as a reduction in cannula lifetime due to cyclic mechanical wear of the 
compliant section are also potential limitations that must be investigated. However the 
occurrences of significant changes in CIC diameter are not anticipated during normal VAD 
operation. Meanwhile, limitations existed with the experimental evaluation in this study, such 
as maintaining constant SVR and PVR while changing VAD speed. This, in turn, elevated 
arterial pressures to unreasonable levels while flow rates increased only mildly, thus causing 
a potential discrepancy between these results and what would be expected clinically. Auto-
regulation of the vascular resistances (ie. through a baroreceptor response) would result in 
larger flow rate changes and thus earlier induced suction events with the RIC and restriction 
of the CIC. Meanwhile, the high cannula resistance, even with the rigid design, was due to 
the long cannula length required for our experimental setup and should be addressed in future 
studies. 
 
  
Conclusion 
The limited preload sensitivity of rotary VADs gives rise to a need for control mechanisms to 
prevent harmful suction events, particularly in biventricular support when the left and right 
ventricular Starling response is severely reduced. While other research has focused on sensor 
and sensor-less based control systems, the reliability of these systems is presently insufficient 
for a destination therapy device. This study evaluated the use of a compliant section of tubing 
on the inflow cannula which passively increased the VAD circuit resistance and thus reduced 
VAD outflow when preload decreased. Compliant and rigid inflow cannulae were evaluated 
under various LVAD and RVAD speeds and severe step changes in SVR and PVR for 
comparison. The ease with which suction events can occur with the use of RIC and no 
physiological control mechanism (i.e. fixed speed) was clearly demonstrated, while the 
addition of the compliant section prevented suction events in all cases. This study revealed a 
CIC may be used as a passive control system to prevent harmful suction events in rotary left, 
right or biventricular support. However, further investigation into several key issues such as 
cannula compliance optimization, possible tissue integration and mechanical 
wear/deterioration must be addressed before clinical implementation. 
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List of Figures 
 
Figure 1 - Simplified schematic of the mock circulation loop (left) with the compliant 
inflow cannulae (right) on the LVAD and RVAD. LA - left atrium, LV - left ventricle, 
Ao - aorta, SVR - systemic vascular resistance, SV - systemic venous system, RA - right 
atrium, RV - right ventricle, PA - pulmonary artery, PVR - pulmonary vascular 
resistance, PV - pulmonary venous system. 
  
  
Figure 2 - An example comparison between compliant and rigid LVAD ventricular 
inflow cannulae with increasing LVAD speed. LVVsys - end systolic left ventricular 
volume, LVADRin - LVAD inflow cannula resistance, MSQ - mean systemic flow rate. 
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 Figure 3 - Comparison of compliant and rigid LVAD inflow cannulae for atrial (left) 
and ventricular (right) cannulation. LAP - left atrial pressure, LVVsys - end systolic left 
ventricular volume. 
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 Figure 4 - Comparison of compliant and rigid RVAD inflow cannulae for atrial (left) 
and ventricular (right) cannulation. RAP - right atrial pressure, RVVsys - end systolic 
right ventricular volume. 
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List of Tables 
 
LVAD Rigid Inflow Compliant Inflow 
Inflow cannulation LA LA LV LV LA LA LV LV 
PVR (Dynes.s.cm-5) 100 400 100 400 100 400 100 400 
LAP (mmHg) 7.9 0 8.8 1.4 7.2 5 8.3 4 
LVVsys (mL) 212 147 132 0 202 112 117 31 
MAP (mmHg) 100 95 100 87 100 67 99 74 
MSQ (L/min) 5 4.65 5 4.4 5.0 3.95 5 4.1 
LVADRin 
(Dynes.s.cm-5) 
490 460 520 490 550 1800 590 1100 
RVAD Rigid Inflow Compliant Inflow 
Inflow cannulation RA RA RV RV RA RA RV RV 
SVR (Dynes.s.cm-5) 1500 2500 1500 2500 1500 2500 1500 2500 
RAP (mmHg) 4.8 0 6.5 -2 4.9 3.1 7 3.2 
RVVsys (mL) 108 71 78 0 110 76 89 27 
MPAP (mmHg) 17.3 16.4 17.3 20 17.3 14 17.2 15 
MPQ (L/min) 5 3.84 5 3.92 5 3.65 5.1 3.75 
RVADRin 
(Dynes.s.cm-5) 
1070 1080 1110 1120 1080 1650 1140 1750 
Table 1 - Haemodynamics for BiVAD support with rigid and compliant inflow cannulae 
in atrial and ventricular cannulation. LA - left atrium, LV - left ventricle, RA - right 
atrium, RV - right ventricle, SVR - systemic vascular resistance, PVR - pulmonary 
vascular resistance, LAP - left atrial pressure, RAP - right atrial pressure, LVVsys - end 
systolic left ventricular volume, RVVsys - end systolic right ventricular volume, MAP - 
mean aortic pressure, MPAP - mean pulmonary arterial pressure, MSQ - mean 
systemic flow rate, MPQ - mean pulmonary flow rate, LVADRin - LVAD inflow 
cannula resistance, RVADRin - RVAD inflow cannula resistance. 
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